Formulary Delisting

Formulary Delisting is a policy-level decision within health care pharmacoeconomic management that removes a pharmaceutical agent from a covered drug list, thereby restricting its reimbursement or coverage under a specified insurance or managed care formulary.

3

Publications

40

Citations

15

Authors

2

Institutions

Publications per year

2017–2026

1

Authors

15

  1. DM
    D.A.E. Mowat

    Queen's University, Canada

    1 publications · 10 citations

    1

    h-index

  2. RD
    Rachel Devitt

    University of Toronto, Canada

    1 publications · 13 citations

    1

    h-index

  3. KZ
    Khalid Zaman

    University of Haripur, Pakistan

    1 publications · 17 citations

    1

    h-index

  4. CC
    Cheryl Cott

    University of Toronto, Canada

    1 publications · 13 citations

    1

    h-index

  5. MG
    Melanie Gordon

    University of Illinois Chicago, United States

    1 publications · 13 citations

    1

    h-index

1–5 of 15

Institutions

2

  1. Queen's University

    Kingston, Canada

    1 h-index

    1 publications

    10 citations

  2. University of Haripur

    Islamabad, Pakistan

    1 h-index

    1 publications

    17 citations

1–2 of 2

Venues

  1. Munich Personal RePEc Archive (Munich University)

    Repository · 1 publications · 17 citations

    1

    h-index

  2. Physiotherapy Canada

    1 publications · 13 citations

    1

    h-index

  3. PubMed

    Repository · 1 publications · 10 citations

    1

    h-index

1–3